Search Within

Alexia Elia Iasonos

Formats
  1. Journal Article (239)
  2. Meeting Abstract (110)
  3. Editorial (4)
  4. Review (3)
  5. Correspondence (2)
  6. Miscellaneous (2)
  7. Book Section (1)
  8. Book Whole (1)
  9. Conference Paper (1)
Groups
  1. Biostatistics Service (363)
  2. Epidemiology and Biostatistics (363)
  3. Gynecology Disease Management Team (251)
  4. Department of Medicine (249)
  5. Solid Tumor Oncology Division (236)
  6. Surgery (199)

More Groups

People
  1. Qin Zhou (191)
  2. Nadeem Abu-Rustum (123)
  3. Carol Aghajanian (115)
  4. Dennis Chi (102)
  5. Roisin O'Cearbhaill (75)
  6. Yukio Sonoda (73)

More People

Years
  1. 2025 (9)
  2. 2024 (38)
  3. 2023 (36)
  4. 2022 (22)
  5. 2021 (27)
  6. 2020 (28)

More Years

Publications
  1. Gynecologic Oncology (106)
  2. Journal of Clinical Oncology (74)
  3. International Journal of Gynecological Cancer (44)
  4. Clinical Cancer Research (18)
  5. Cancer (14)
  6. Statistics in Medicine (9)

More Publications

Publishers
  1. Elsevier Inc. (113)
  2. American Society of Clinical Oncology (79)
  3. Lippincott Williams & Wilkins (53)
  4. American Association for Cancer Research (25)
  5. Wiley Blackwell (19)
  6. John Wiley & Sons (11)

More Publishers

Results (363)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Quantifying treatment benefit in molecular subgroups to assess a predictive biomarker
    Meeting Abstract

    Satagopan, J. M.; Iasonos, A.
    Genetic Epidemiology (2016)

    Fulltext@MSK | Save
  • Dimension of model parameter space and operating characteristics in adaptive dose-finding studies
    Journal Article

    Iasonos, A.; Wages, N. A.; Conaway, M. R.; Cheung, K.; Yuan, Y.; O'Quigley, J.
    Statistics in Medicine (2016)

    Fulltext@MSK | Save
  • Integrating the escalation and dose expansion studies into a unified Phase I clinical trial
    Journal Article

    Iasonos, A.; O'Quigley, J.
    Contemporary Clinical Trials (2016)

    Fulltext@MSK | Save
  • Dose expansion cohorts in Phase I trials
    Journal Article

    Iasonos, A.; O’Quigley, J.
    Statistics in Biopharmaceutical Research (2016)

    Fulltext@MSK | Save
  • Reply to M.P. Decatris et al
    Journal Article

    Hyman, D. M.; Solit, D. B.; Iasonos, A.
    Journal of Clinical Oncology (2016)

    Fulltext@MSK | Save
  • Beyond the dose-limiting toxicity period: Dermatologic adverse events of patients on phase 1 trials of the Cancer Therapeutics Evaluation Program
    Journal Article

    Drilon, A.; Eaton, A. A.; Schindler, K.; Gounder, M. M.; Spriggs, D. R.; Harris, P.; Ivy, S. P.; Iasonos, A.; Lacouture, M. E.; Hyman, D. M.
    Cancer (2016)

    Fulltext@MSK | Save
  • Measuring toxicity in phase I clinical trials-letter — Letter
    Journal Article

    Hyman, D. M.; Eaton, A.; Ivy, S. P.; Spriggs, D. R.; Iasonos, A.
    Clinical Cancer Research (2016)

    Fulltext@MSK | Save
  • Quantifying treatment benefit in molecular subgroups to assess a predictive biomarker
    Journal Article

    Iasonos, A.; Chapman, P. B.; Satagopan, J. M.
    Clinical Cancer Research (2016)

    Fulltext@MSK | Save
  • A phase I study of unimolecular pentavalent (Globo-H-GM2-sTn-TF-Tn) immunization of patients with epithelial ovarian, fallopian tube, or peritoneal cancer in first remission
    Journal Article

    O’Cearbhaill, R. E.; Ragupathi, G.; Zhu, J.; Wan, Q.; Mironov, S.; Yang, G.; Spassova, M. K.; Iasonos, A.; Kravetz, S.; Ouerfelli, O.; more...
    Cancers (2016)

    Fulltext@MSK | Save
  • An assessment of prognostic factors, adjuvant treatment, and outcomes of stage IA polyp-limited versus endometrium-limited type II endometrial carcinoma
    Journal Article

    Liang, L. W.; Perez, A. R.; Cangemi, N. A.; Zhou, Q.; Iasonos, A.; Abu-Rustum, N.; Alektiar, K. M.; Makker, V.
    International Journal of Gynecological Cancer (2016)

    Fulltext@MSK | Save